ArticleSurgery2021

A novel heat shock protein inhibitor KU757 with efficacy in lenvatinib-resistant follicular thyroid cancer cells overcomes up-regulated glycolysis in drug-resistant cells in vitro.

Chitra Subramanian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.